Stanford University

Home Page:
   
Number of Awards: 42 Award Total: $18,008,124
 
Investigators
Michael  Antecol , Ph.D. - Qizhen  Cao , Ph.D. - Ching-Pin  Chang , M.D., PH.D - John  Cooke , M.D., Ph.D. - John  Cooke , M.D., Ph.D. - John  Cooke , M.D., Ph.D. - John  Cooke , M.D., Ph.D. - Edgar  Engleman , M.D. - Stephen  Fortmann , M.D. - Stephen  Fortmann , M.D. - Heinz  Furthmayr , M.D. - Gary  Gibbons , M.D. - Joshua  Grimley , B.S., B.S. - Lisa  Henriksen , Ph.D. - Lisa  Henriksen , Ph.D. - Lisa  Henriksen , Ph.D. - Lynn  Hildemann , Ph.D. - Kehkooi  Kee , Ph.D. - Joel  Killen , Ph.D. - Joel  Killen , Ph.D. - Joel  Killen , Ph.D. - Nolan  Ko , Ph.D. - Matthew  Kohrman , Ph.D. - Kevin  Kwei , Ph.D. - Kate  Lorig , Ph.D. - Anson  Lowe , M.D. - Albert  Macovski , Ph.D. - Greer  Murphy , M.D., Ph.D. - Lorene  Nelson , Ph.D. - Lorene  Nelson , Ph.D. - Dwight  Nishimura , Ph.D. - Thomas  Raffin , M.D. - Thomas  Raffin , M.D. - Gerald  Reaven , M.D. - Renee  Reijo Pera , Ph.D. - Stephen  Ruoss , M.D. - Robert  Sapolsky , Ph.D. - Paul  Switzer , Ph.D. - C. Barr  Taylor , M.D. - Philip  Tsao , Ph.D. - Damian  Wheeler , B.SC., Ph.D. - Jerome  Yesavage , M.D. -
   

Grants

Title Cycle [sort] Award
     
Allocation of Health Care to Smokers: Practice and Ethics 1998 (Cycle VII) $113,598
 Investigator(s): Thomas  Raffin , M.D. 7IT-0129
 
Association of Outlet Density with Smoking and Pack Price 2008 (Cycle XVII) $516,285
 Investigator(s): Lisa  Henriksen , Ph.D. 17RT-0152
 
Comprehensive evaluation of the ischemic leg 2000 (Cycle IX) $672,390
 Investigator(s): Dwight  Nishimura , Ph.D. 9RT-0024
 
Controlled study of withdrawal symptoms in teen smokers 2003 (Cycle XII) $499,890
 Investigator(s): Joel  Killen , Ph.D. 12RT-0141
 
Development of a blood test for pancreatic cancer 1997 (Cycle VI) $308,819
 Investigator(s): Anson  Lowe , M.D. 6RT-0439
 
Dissemination of a smoking cessation program for in patients 1999 (Cycle VIII) $710,621
 Investigator(s): C. Barr  Taylor , M.D. 8RT-0031
 
Dysregulation of VSMC signaling induced by nicotine 2001 (Cycle X) $683,510
 Investigator(s): Philip  Tsao , Ph.D. 10RT-0298
 
Effect of tobacco toxins on human germ cell development 2006 (Cycle XV) $41,710
 Investigator(s): Kehkooi  Kee , Ph.D. 15FT-0178A
 
Effects of nicotine withdrawal on aviator performance 2001 (Cycle X) $515,243
 Investigator(s): Jerome  Yesavage , M.D. 10RT-0186
 
Effects of Outlet/Ad Density on Teen Smking and Brand Choice 2005 (Cycle XIV) $410,979
 Investigator(s): Lisa  Henriksen , Ph.D. 14RT-0103
 
Effects of pro and anti-smoking cues in stores on craving 2004 (Cycle XIII) $373,894
 Investigator(s): Lisa  Henriksen , Ph.D. 13RT-0123
 
Effects of PSA content and formal features on smoking norms 1999 (Cycle VIII) $44,284
 Investigator(s): Michael  Antecol , Ph.D. 8FT-0149
 
Effects of Selegiline on craving for nicotine 1998 (Cycle VII) $100,450
 Investigator(s): Joel  Killen , Ph.D. 7RT-0094
 
Exposure to Secondhand Smoke: Effects of Proximity 2007 (Cycle XVI) $672,582
 Investigator(s): Lynn  Hildemann , Ph.D. 16RT-0150
 
Genetic links to nicotine addiction: ethics of testing teens 1999 (Cycle VIII) $115,591
 Investigator(s): Thomas  Raffin , M.D. 8IT-0123
 
Genomic Assay to Identify Targets of Anticancer Therapeutics 2008 (Cycle XVII) $75,000
 Investigator(s): Nolan  Ko , Ph.D. 17FT-0056
 
Human oocyte development and PAH exposure 2005 (Cycle XIV) $158,556
 Investigator(s): Renee  Reijo Pera , Ph.D. 14RT-0159A
 
Interactions of Moesin during platelet activation 1995 (Cycle IV) $428,524
 Investigator(s): Heinz  Furthmayr , M.D. 4RT-0316
 
Life histories: Chinese-American elders' smoking encounters 2000 (Cycle IX) $17,146
 Investigator(s): Matthew  Kohrman , Ph.D. 9IT-0066
 
Mechanisms by which tobacco accelerates atherosclerosis 1998 (Cycle VII) $675,731
 Investigator(s): John  Cooke , M.D., Ph.D. 7RT-0128
 
Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco 1994 (Cycle III) $314,974
 Investigator(s): Gary  Gibbons , M.D. 3KT-0375
 
Mechanisms of Tobacco-Induced Retinal Neovascularization 2006 (Cycle XV) $155,550
 Investigator(s): John  Cooke , M.D., Ph.D. 15IT-0257
 
Mobilized dendritic cells for lung cancer 2000 (Cycle IX) $950,821
 Investigator(s): Edgar  Engleman , M.D. 9RT-0229
 
Nicotine and congenital heart disease 2008 (Cycle XVII) $629,797
 Investigator(s): Ching-Pin  Chang , M.D., PH.D 17RT-0102
 
Nicotine effects on gene expression and metaplasticity 2004 (Cycle XIII) $74,500
 Investigator(s): Damian  Wheeler , B.SC., Ph.D. 13FT-0059
 
Nicotine-pathological angiogenesis and genetic determinants 2002 (Cycle XI) $608,420
 Investigator(s): John  Cooke , M.D., Ph.D. 11RT-0147
 
Nicotinic receptors, smoking and Parkinson's Disease 2002 (Cycle XI) $765,971
 Investigator(s): Lorene  Nelson , Ph.D. 11RT-0237
 
Novel imaging methods for diagnosing tobacco related cancers 1997 (Cycle VI) $629,087
 Investigator(s): Albert  Macovski , Ph.D. 6RT-0384
 
Novel strategy for protecting neurons from injury in stroke 1999 (Cycle VIII) $742,809
 Investigator(s): Robert  Sapolsky , Ph.D. 8RT-0073
 
NRT and paroxetine for smoking cessation 1997 (Cycle VI) $646,916
 Investigator(s): Joel  Killen , Ph.D. 6RT-0041
 
Parkinson's Disease: A Protective Effect of Smoking? 1999 (Cycle VIII) $512,849
 Investigator(s): Lorene  Nelson , Ph.D. 8RT-0131
 
Pharmacogenetics of Smoking Cessation 2006 (Cycle XV) $653,384
 Investigator(s): Greer  Murphy , M.D., Ph.D. 15RT-0113
 
Quantification of population exposure to secondhand smoke 1997 (Cycle VI) $686,858
 Investigator(s): Paul  Switzer , Ph.D. 6RT-0118
 
Reducing provision of tobacco to minors from social sources 1998 (Cycle VII) $639,838
 Investigator(s): Stephen  Fortmann , M.D. 7RT-0156
 
Role of lineage-specific oncogene TITF1 in lung cancer 2008 (Cycle XVII) $75,000
 Investigator(s): Kevin  Kwei , Ph.D. 17FT-0062
 
Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis 1994 (Cycle III) $175,409
 Investigator(s): Stephen  Ruoss , M.D. 3KT-0222A
 
SHS Exacerbates cerebral ischemia: endothelial mechanisms 2005 (Cycle XIV) $654,854
 Investigator(s): John  Cooke , M.D., Ph.D. 14RT-0169
 
Smoking, insulin resistance, and endothelial dysfunction 2003 (Cycle XII) $814,989
 Investigator(s): Gerald  Reaven , M.D. 12RT-0159
 
Spanish tobacco-related disease self-management: evaluation 1997 (Cycle VI) $693,751
 Investigator(s): Kate  Lorig , Ph.D. 6RT-0107
 
Synthesis and Evaluation of Anticancer Agent Celogentin C 2006 (Cycle XV) $29,500
 Investigator(s): Joshua  Grimley , B.S., B.S. 15DT-0015
 
Targeted Imaging and Therapy of Lung Cancer 2008 (Cycle XVII) $75,000
 Investigator(s): Qizhen  Cao , Ph.D. 17FT-0054
 
Tests of the tobacco industry's youth smoking prevention ads 2000 (Cycle IX) $343,044
 Investigator(s): Stephen  Fortmann , M.D. 9RT-0138